|
MINPP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.91880000566647E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.5751958605299E-11 |
| Normal-vs-Stage2 |
3.030300E-02 |
| Normal-vs-Stage3 |
1.099030E-01 |
| Normal-vs-Stage4 |
6.714600E-01 |
| Stage1-vs-Stage2 |
7.786300E-02 |
| Stage1-vs-Stage3 |
2.343800E-03 |
| Stage1-vs-Stage4 |
5.676300E-02 |
| Stage2-vs-Stage3 |
4.594000E-01 |
| Stage2-vs-Stage4 |
3.470400E-01 |
| Stage3-vs-Stage4 |
6.433800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.28169968766679E-10 |
| Normal-vs-AfricanAmerican |
1.577620E-04 |
| Normal-vs-Asian |
9.153000E-01 |
| Caucasian-vs-AfricanAmerican |
4.362500E-02 |
| Caucasian-vs-Asian |
3.030000E-01 |
| AfricanAmerican-vs-Asian |
4.700400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.19609894106065E-11 |
| Normal-vs-Female |
1.433830E-02 |
| Male-vs-Female |
7.5370000000019E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.41759999999314E-05 |
| Normal-vs-Extreme_Weight |
1.92523774700248E-12 |
| Normal-vs-Obese |
5.82619999999201E-05 |
| Normal-vs-Extreme_Obese |
2.957600E-04 |
| Normal_Weight-vs-Extreme_Weight |
6.299900E-02 |
| Normal_Weight-vs-Obese |
4.582000E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.622800E-01 |
| Extreme_Weight-vs-Obese |
1.557060E-03 |
| Extreme_Weight-vs-Extreme_Obese |
1.728390E-01 |
| Obese-vs-Extreme_Obese |
6.046000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.554000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.85529999996437E-06 |
| Normal-vs-Age(61-80Yrs) |
1.14710019261111E-10 |
| Normal-vs-Age(81-100Yrs) |
4.76600000021143E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.020400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.277700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.017640E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.588000E-04 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.212400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.774400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.18730034085013E-10 |
| Normal-VS-Type2 PRCC |
2.48979999999399E-05 |
| Normal-VS-KIRP CIMP |
8.324400E-02 |
| Normal-VS-Unclassified PRCC |
2.68999999997188E-06 |
| Type1 PRCC-VS-Type2 PRCC |
9.899000E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.822360E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
3.728800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.90991999999834E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
3.300400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.022200E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.03200000001191E-06 |
| Normal-vs-N1 |
7.334200E-01 |
| Normal-vs-N2 |
4.115200E-01 |
| N0-vs-N1 |
3.442300E-04 |
| N0-vs-N2 |
5.394600E-01 |
| N1-vs-N2 |
3.197800E-01 |
|
|
